InsidersTradesSigma
Follow the 华熙生物 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华熙生物 has recorded 6 public disclosures. Market capitalisation: €17.5bn. The latest transaction was disclosed on 5 September 2025 (Purchase). Among the most active insiders: 赵毅. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
华熙生物 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research and development of biological and pharmaceutical products.